PLOD3 and cancer: In the 18 cancer types from TCGA, we calculated tissues with mutations of ADAM12, MMP1, SERPINE1, PLOD3, and P4HA3, and they had limited mutations, and their mutation sites had few significant effects on gene expression or function gain across the 18 cancer types (Table S3, Figure S8A–D).